Allurion Technologies

Allurion Technologies, founded in 2009, is a developer of devices focused on the treatment of obesity. They have developed a simple and convenient treatment method that helps people lose weight easily through innovative, personalized, and reliable experiences. The Elipse program has been used by tens of thousands of people worldwide and is rapidly becoming the preferred weight loss solution in Europe, the Middle East, and South America. Throughout the Elipse program, doctors provide guidance and advice to help obese individuals develop healthy lifestyle habits. Additionally, connected smart scales and apps track users' weight loss progress. The smart scale helps monitor key metrics such as weight, body fat, and BMI to ensure the weight loss plan proceeds as expected. Allurion's core product is Elipse, an easy-to-use swallowable gastric balloon contained within a capsule. Under medical supervision, the user swallows the capsule, and the doctor fills it with liquid using a thin delivery catheter. Once the capsule reaches the stomach, the balloon detaches from the capsule and inflates, remaining in the stomach for approximately four months. During this time, it creates a feeling of fullness, reducing food intake and thereby achieving weight loss.